EUVIMEDEUVIMED entdecken
Open Access

Long-Term Prognostic Value of 82 Rb PET/CT–Determined Myocardial Perfusion and Flow Reserve in Cancer Patients

Josef J Fox, Audrey Mauguen, Kimiteru Ito, Dipti Gupta, Alice Yu, Thomas H Schindler, H William Strauss, Heiko Schöder

Journal of Nuclear Medicine · 2023

DOI: 10.2967/jnumed.122.264795 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Josef J Fox und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Hauptthemen laut MEDLINE: Coronary Artery Disease, Neoplasms, Myocardial Perfusion Imaging, Fractional Flow Reserve, Myocardial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial flow reserve (MFR), derived from quantitative measurements of myocardial blood flow during PET imaging, provides prognostic information on patients with coronary artery disease (CAD), but it is not known if this also applies to cancer patients with a competing risk for mortality.

Methods

To determine the prognostic value of MFR in patients with cancer, we designed a retrospective cohort study comprising 221 patients with known or suspected CAD (median age, 71 y; range, 41-92 y) enrolled between June 2009 and January 2011. Most patients were referred for perioperative risk assessment. Patients underwent measurement of myocardial blood flow at rest and during pharmacologic stress, using quantitative 82Rb PET imaging. They were divided into early-stage versus advanced-stage cancer groups based on cancer histopathology and clinical state and were further stratified by myocardial perfusion summed stress score, summed difference score, and calculated MFR. Overall survival (OS) was assessed using the Kaplan-Meier estimator, and Cox proportional-hazards regression helped identify independent predictors for OS.

Results

During a follow-up of 85.6 mo, 120 deaths occurred. MFR, summed difference score, and cancer stage were significantly associated with OS. In the age-adjusted Cox hazard multivariable analysis, MFR and cancer stage remained independent prognostic factors. MFR combined with cancer stage enhanced OS discrimination. The groups had significantly different outcomes (P < 0.001), with 5-y OS of 88% (MFR ≥ 1.97 and early-stage), 53% (MFR < 1.97 and early-stage), 33% (MFR ≥ 1.97 and advanced-stage), and 13% (MFR < 1.97 and advanced-stage).

Conclusion

Independent of cancer stage, MFR derived from quantitative PET was prognostic of OS in our cohort of cancer patients with known or suspected CAD. Combining these 2 parameters enhanced discrimination of OS, suggesting that MFR improves risk stratification and may serve as a treatment target to increase survival in cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseNeoplasmsMyocardial Perfusion ImagingFractional Flow Reserve, MyocardialHumansAgedPositron Emission Tomography Computed TomographyPrognosisRetrospective StudiesPositron-Emission TomographyPerfusionCoronary Circulation

Stichwörter der Autor:innen

cancermyocardial flow reservequantitative myocardial perfusion imagingrubidium PETsurvival

Autor:innen und Institutionen

  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and.
  • Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; schoderh@mskcc.org.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Fox, J. J., Mauguen, A., Ito, K., Gupta, D., Yu, A., Schindler, T. H., Strauss, H. W., & Schöder, H. (2023). Long-Term Prognostic Value of 82 Rb PET/CT–Determined Myocardial Perfusion and Flow Reserve in Cancer Patients. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.122.264795

Vancouver

Fox JJ, Mauguen A, Ito K, Gupta D, Yu A, Schindler TH, et al. Long-Term Prognostic Value of 82 Rb PET/CT–Determined Myocardial Perfusion and Flow Reserve in Cancer Patients. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.122.264795

BibTeX
@article{Fox2023,
  author = {Fox, Josef J and Mauguen, Audrey and Ito, Kimiteru and Gupta, Dipti and Yu, Alice and Schindler, Thomas H and Strauss, H William and Schöder, Heiko},
  title = {Long-Term Prognostic Value of 82 Rb PET/CT–Determined Myocardial Perfusion and Flow Reserve in Cancer Patients},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  doi = {10.2967/jnumed.122.264795}
}
Kostenlos starten →